Shenzhen Oriental Fortune Capital

Shenzhen, China · DeepTech Native
Tier 3 Industrial

Bio

Shenzhen Oriental Fortune Capital Shenzhen Oriental Fortune Capital is a major Chinese VC managing ¥20B+ (RMB) since 2006, with a portfolio of 500+ companies and 100+ IPO exits. The fund focuses on healthcare, biopharma, medical devices, and life sciences while also being active in hard tech sectors including semiconductors, advanced manufacturing, and new materials. Government-backed with deep connections to the Shenzhen ecosystem. China's hardware and manufacturing capital. Oriental Fortune

Industries

BiotechMedTechAI Infrastructure

Stages

Series ASeries B+

Geography

China

Notable investments

  • Fosun Pharma
  • Walvax Biotechnology